Bristol-Myers Squibb Company Revenue 2007–2025
Bristol-Myers Squibb Company annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bristol-Myers Squibb Company revenue for the quarter ending March 31, 2026 was 11.5 B, a 2.57% increase year-over-year.
- Bristol-Myers Squibb Company revenue for the twelve months ending March 31, 2026 was 47.2 B, a 0.55% increase year-over-year.
- Bristol-Myers Squibb Company annual revenue for 2025 was 48.2 B, a 0.22% decrease from 2024.
- Bristol-Myers Squibb Company annual revenue for 2024 was 48.3 B, a 7.32% increase from 2023.
- Bristol-Myers Squibb Company annual revenue for 2023 was 45.0 B, a 2.50% decrease from 2022.
- Bristol-Myers Squibb Company annual revenue for 2022 was 46.2 B.
Bristol-Myers Squibb Company (BMY) — Frequently Asked Questions
Bristol-Myers Squibb Company (BMY) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $113.37B. In fiscal 2025 it reported revenue of $48.19B and net income of $7.05B. Explore BMY's stock price, financial statements, earnings history, margins and key ratios below.
What is Bristol-Myers Squibb Company's market cap?
Bristol-Myers Squibb Company (BMY) has a market capitalization of $113.37B.
What is the BMY stock price?
BMY trades at $55.60 (-1.56% on the day).
How much revenue does Bristol-Myers Squibb Company make?
Bristol-Myers Squibb Company reported revenue of $48.19B in fiscal 2025.
Is BMY profitable?
In fiscal 2025, Bristol-Myers Squibb Company reported net income of $7.05B.
What is BMY's P/E ratio?
Based on diluted EPS, BMY has a price-to-earnings (P/E) ratio of about 16.1.